home · filing · 0001493152-24-015344
8-K filed April 19, 2024, 7:59 PM ET
ticker BIXT
CIK 0001445815
other material
confidence high
sentiment neutral
materiality 0.60
Bioxytran creates insider-only convertible preferred with 10 votes per share; appoints Dr. Radka Milanova to board
BIOXYTRAN, INC
Board designated 49.5M of 50M authorized preferred shares as Convertible Preferred Stock with 10 votes per share on as-converted basis.
Exchange ratio: 5 common shares for 1 preferred share; conversion ratio: 1 preferred share for 5 common shares.
Only common shares held by insiders (officers, directors) are eligible to exchange into the new preferred stock.
Dr. Radka Milanova (PhD, Organic Chemistry) appointed to fill board vacancy left by deceased Dr. Chen-Walden.
Dr. Milanova receives $5,000 in common stock per attended board/committee meeting; no cash compensation.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Dr. Radka Milanova
Director
Effective 2024-04-19
Filed April 19, 2024, 7:59 PM ET
Effective as of April 19, 2024, the Company has elected Dr. Radka Milanova, to fill the vacancy left by Dr. Chen-Walden, (now deceased).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Radka Milanova was elected as Director at BIOXYTRAN, INC.
Action elected
Role Director
Exact text from the filing
Effective as of April 19, 2024, the Company has elected Dr. Radka Milanova, to fill the vacancy left by Dr. Chen-Walden, (now deceased).
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-015344
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.